Literature DB >> 12675638

Pathophysiological implications of insulin resistance on vascular endothelial function.

S B Wheatcroft1, I L Williams, A M Shah, M T Kearney.   

Abstract

BACKGROUND: Insulin resistance is a key component of the insulin resistance syndrome and is a crucially important metabolic abnormality in Type 2 diabetes. Insulin-resistant individuals are at significantly increased risk of cardiovascular disease, although the underlying mechanisms remain incompletely understood. The endothelium is thought to play a critical role in maintaining vascular homeostasis, a process dependent on the balance between the production of nitric oxide, superoxide and other vasoactive substances. Endothelial dysfunction has been demonstrated in insulin-resistant states in animals and humans and may represent an important early event in the development of atherosclerosis. Insulin resistance may be linked to endothelial dysfunction by a number of mechanisms, including disturbances of subcellular signalling pathways common to both insulin action and nitric oxide production. Other potential unifying links include the roles of oxidant stress, endothelin, the renin angiotensin system and the secretion of hormones and cytokines by adipose tissue. Lifestyle measures and drug therapies which improve insulin sensitivity and ameliorate endothelial dysfunction may be important in delaying the progression to overt cardiovascular disease in at risk individuals.
METHODS: We conducted a literature search using Medline, restricted to articles published in the English language between 1966 and the present, and reviewed bibliographies of relevant articles. An initial search strategy employing combinations of the MeSH terms: insulin resistance; endothelium, vascular; insulin; nitric oxide or hyperinsulinaemia produced over 300 references. Focused searches using keywords relevant to the molecular aspects of endothelial function and insulin signalling, and lifestyle or pharmacological interventions relevant to insulin resistance or endothelial function, produced over 300 further references. Abstracts of all references were screened before selecting those relevant to this review.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12675638     DOI: 10.1046/j.1464-5491.2003.00869.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  50 in total

Review 1.  Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2015-12       Impact factor: 1.894

Review 2.  The future of endothelin-receptor antagonism as treatment for systemic hypertension.

Authors:  Gabriel Vorobiof; Burns C Blaxall; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

3.  The operative risk factors in the metabolic syndrome: is it lipids and high BP or are there direct vascular effects of insulin resistance and obesity.

Authors:  Fabrice M A C Martens; Frank L J Visseren
Journal:  Curr Diab Rep       Date:  2007-02       Impact factor: 4.810

Review 4.  Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.

Authors:  Corey E Tabit; William B Chung; Naomi M Hamburg; Joseph A Vita
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

5.  Suppression of eNOS-derived superoxide by caveolin-1: a biopterin-dependent mechanism.

Authors:  Kanchana Karuppiah; Lawrence J Druhan; Chun-an Chen; Travis Smith; Jay L Zweier; William C Sessa; Arturo J Cardounel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-07-01       Impact factor: 4.733

6.  Chronic kidney disease, insulin resistance, and incident diabetes in older adults.

Authors:  Hien Pham; Cassianne Robinson-Cohen; Mary L Biggs; Joachim H Ix; Kenneth J Mukamal; Linda F Fried; Bryan Kestenbaum; David S Siscovick; Ian H de Boer
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 8.237

7.  Insulin and insulin resistance.

Authors:  Gisela Wilcox
Journal:  Clin Biochem Rev       Date:  2005-05

Review 8.  Antihypertensive treatment and new-onset diabetes mellitus.

Authors:  Tonje Amb Aksnes; Henrik M Reims; Sverre E Kjeldsen; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

9.  Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease.

Authors:  Naomi M Hamburg; Martin G Larson; Joseph A Vita; Ramachandran S Vasan; Michelle J Keyes; Michael E Widlansky; Caroline S Fox; Gary F Mitchell; Daniel Levy; James B Meigs; Emelia J Benjamin
Journal:  Am J Cardiol       Date:  2008-01-01       Impact factor: 2.778

Review 10.  The IGF-1 receptor and regulation of nitric oxide bioavailability and insulin signalling in the endothelium.

Authors:  V Kate Gatenby; Helen Imrie; Mark Kearney
Journal:  Pflugers Arch       Date:  2013-01-22       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.